Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol disodium vs propofol for general anesthesia in ERCP
ChiCTR2500114482Phase 4Not yet recruiting
- Sponsor
- Luxian People's Hospital
- Start
- Aug 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fospropofol disodium in pancreaticobiliary diseases (2 arms), sponsored by Luxian People's Hospital. Primary endpoints: Anesthesia Success Rate for ERCP and Incidence of Adverse Events. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
pancreaticobiliary diseases
Beyond the preview
Go deeper on ChiCTR2500114482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114482.